FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of biochemistry, in particular to antibodies, which bind with human HER3, to the method of their production, to pharmaceutical compositions, containing the said antibodies, and to application thereof for cancer treatment.
EFFECT: invention makes it possible to effectively slow down the growth of cancer cells, expressing HER3, and HER3-mediated signal transmission.
14 cl, 6 dwg, 13 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ALLOSTERIC ANTIBODIES AGAINST HUMAN HER3 NON COMPETITIVE FOR NEUREGULIN AND USE THEREOF | 2013 |
|
RU2704228C2 |
| BISPECIFIC ANTIBODIES | 2011 |
|
RU2573588C2 |
| BINDING MOLECULE SPECIFIC FOR HER3, AND THEIR APPLICATIONS | 2012 |
|
RU2620068C2 |
| ANTIGEN-BINDING PROTEINS | 2012 |
|
RU2607038C2 |
| TRISPECIFIC BINDING MOLECULES, WHICH SPECIFICALLY BIND ANTIGENS OF A VARIETY OF MALIGNANT TUMORS, AND METHODS OF USING THEM | 2015 |
|
RU2718692C2 |
| IL2 ANTIBODIES | 2006 |
|
RU2425054C2 |
| EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY | 2013 |
|
RU2652880C2 |
| ANTIBODIES TO PD-1 AND METHODS OF THEIR APPLICATION | 2015 |
|
RU2701797C2 |
| ANTI-ICOS ANTIBODIES | 2017 |
|
RU2764548C2 |
| ANTIBODIES SPECIFIC TO BTN2 AND THEIR APPLICATIONS | 2018 |
|
RU2794996C2 |
